Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
184.31
+0.27 (0.15%)
Dec 5, 2025, 4:00 PM EST - Market closed
CRL Revenue
Charles River Laboratories International had revenue of $1.00B in the quarter ending September 27, 2025, a decrease of -0.49%. This brings the company's revenue in the last twelve months to $4.02B, down -0.92% year-over-year. In the year 2024, Charles River Laboratories International had annual revenue of $4.05B, down -1.92%.
Revenue (ttm)
$4.02B
Revenue Growth
-0.92%
P/S Ratio
2.29
Revenue / Employee
$200,184
Employees
20,100
Market Cap
9.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 28, 2024 | 4.05B | -79.42M | -1.92% |
| Dec 30, 2023 | 4.13B | 153.35M | 3.86% |
| Dec 31, 2022 | 3.98B | 435.90M | 12.31% |
| Dec 25, 2021 | 3.54B | 616.23M | 21.08% |
| Dec 26, 2020 | 2.92B | 302.71M | 11.55% |
| Dec 28, 2019 | Pro | Pro | Pro |
| Dec 29, 2018 | Pro | Pro | Pro |
| Dec 30, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 26, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
CRL News
- 1 day ago - T. Rowe Price Transitions to Charles River's Enterprise Multi-Asset Investment Management Platform - Business Wire
- 2 days ago - Charles River Laboratories International, Inc. (CRL) Presents at Evercore 8th Annual Healthcare Conference Transcript - Seeking Alpha
- 4 days ago - HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PRNewsWire
- 4 days ago - Charles River Laboratories to Present at Evercore Healthcare Conference - Business Wire
- 14 days ago - Madison Small Cap Fund Q3 2025 Portfolio Activity - Seeking Alpha
- 17 days ago - Charles River Laboratories International, Inc. (CRL) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 17 days ago - SOLVE and Charles River Development Partner to Deliver Integrated Fixed Income Pricing for Investment Managers - Business Wire
- 18 days ago - Charles River Laboratories to Present at Jefferies Global Healthcare Conference - Business Wire